# Johnson Controls International (JCI) â€“ Financial Analysis

**Date:** November 5, 2025  
**Analyst:** Investment Analysis Repository

## Executive Summary

**BLUF: Johnson Controls demonstrates improving financial health with strong cash generation ($2.87B TTM free cash flow), record $14.6B backlog providing visibility, and accelerating margin expansion (17.6% segment EBITA margin, up 20 bps). However, the company faces challenges including negative working capital (-$776M), high leverage (68% debt/equity), and China exposure risk. The recent appointment of new CEO Joakim Weidemanis brings operational transformation potential through lean business system implementation. **Recommendation: Cautiously optimistic** - Strong execution track record and transformation initiatives support upside, but portfolio review and margin gap to peers warrant monitoring.**

---

## Revenue Performance

### Revenue Growth Analysis
| Metric                        | TTM        | 9/30/2024  | 9/30/2023  | 9/30/2022  | 9/30/2021  |
|-------------------------------|------------|------------|------------|------------|------------|
| Total Revenue                 | 23,402,000 | 22,952,000 | 22,331,000 | 20,637,000 | 23,668,000 |
| YoY Growth                    | 2.0%       | 2.8%       | 8.2%       | -12.8%     | --         |

**Key Observations:**
- TTM revenue of $23.4B shows modest 2.0% growth year-over-year
- Q3 FY2025 organic sales growth of 6% demonstrates acceleration from recent trends
- Revenue recovery from FY2021 dip ($23.7B) to FY2022 trough ($20.6B) showing positive trajectory
- Strong backlog growth of 11% to $14.6B provides visibility into future revenue

### Revenue Quality
- **Service Revenue:** ~$5.5B (23% of total) - Higher margin, recurring revenue stream
- **Systems Revenue:** ~$11.7B (50% of total) - Project-based, more cyclical
- **Geographic Mix:** Americas (~$16B, 70%), EMEA (~$5B, 22%), APAC (~$3B, 13%)
- **Order Trends:** Q3 orders +2% (Americas +5%, EMEA +2%, APAC -8% due to China softness)

## Profitability Analysis

### Margin Performance
| Metric                        | TTM        | 9/30/2024  | 9/30/2023  | 9/30/2022  | 9/30/2021  |
|-------------------------------|------------|------------|------------|------------|------------|
| Gross Profit                  | 8,509,000  | 8,077,000  | 7,804,000  | 7,090,000  | 8,059,000  |
| Gross Margin                  | 36.4%      | 35.2%      | 34.9%      | 34.4%      | 34.0%      |
| Operating Income              | 2,898,000  | 2,416,000  | 2,417,000  | 2,012,000  | 2,801,000  |
| Operating Margin              | 12.4%      | 10.5%      | 10.8%      | 9.7%       | 11.8%      |
| Adjusted Segment EBITA Margin | 17.6%      | 16.1%      | --         | --         | --         |

**Key Observations:**
- **Gross Margin:** Improving trend from 34.0% (FY2021) to 36.4% (TTM), indicating pricing power and cost management
- **Operating Margin:** Recovery from 9.7% (FY2022) to 12.4% (TTM), though below FY2021 peak of 11.8%
- **Adjusted Segment EBITA Margin:** 17.6% (Q3 FY2025), up 20 bps QoQ, targeting 90+ bps expansion for FY2025
- **Margin Expansion Drivers:** Lean initiatives, mix shift toward higher-margin solutions, productivity improvements

### Earnings Per Share
| Metric                        | TTM        | 9/30/2024  | 9/30/2023  | 9/30/2022  | 9/30/2021  |
|-------------------------------|------------|------------|------------|------------|------------|
| Diluted EPS                   | 3.36       | 2.52       | 2.69       | 2.19       | 2.27       |
| Adjusted EPS (Q3 FY2025)      | --         | --         | --         | 1.05       | 0.95       |
| EPS Growth (Q3 YoY)           | --         | --         | --         | --         | +11%       |

**Key Observations:**
- TTM diluted EPS of $3.36 represents recovery from FY2022 low of $2.19
- Q3 FY2025 adjusted EPS of $1.05 exceeded guidance, up 11% YoY
- FY2025 guidance raised to $3.65-$3.68 (14-15% growth)

## Balance Sheet Health

### Liquidity Analysis
| Metric                        | 9/30/2024  | 9/30/2023  | 9/30/2022  | 9/30/2021  |
|-------------------------------|------------|------------|------------|------------|
| Cash and Cash Equivalents     | 606,000    | 828,000    | 2,031,000  | 1,336,000  |
| Current Assets                | 11,179,000 | 10,737,000 | 11,685,000 | 9,998,000  |
| Current Liabilities           | 11,955,000 | 11,084,000 | 11,239,000 | 9,098,000  |
| Working Capital               | -776,000   | -347,000   | 446,000    | 900,000    |
| Current Ratio                 | 0.93       | 0.97       | 1.04       | 1.10       |

**Key Observations:**
- **Negative Working Capital:** -$776M is a concern, though improving from -$347M in FY2023
- **Current Ratio:** 0.93 below 1.0, indicating potential liquidity constraints
- **Cash Position:** $606M at FY2024 end, $731M at Q3 FY2025 - adequate for operations
- **Positive Trend:** Working capital improving sequentially, driven by better receivables management

### Leverage Analysis
| Metric                        | 9/30/2024  | 9/30/2023  | 9/30/2022  | 9/30/2021  |
|-------------------------------|------------|------------|------------|------------|
| Total Debt                    | 9,493,000  | 8,824,000  | 8,960,000  | 7,740,000  |
| Net Debt                      | 8,887,000  | 7,996,000  | 6,929,000  | 6,404,000  |
| Net Debt/EBITDA (TTM)         | 2.5x       | 2.7x       | 2.7x       | 1.8x       |
| Total Debt/Equity             | 68.32%     | --         | --         | --         |

**Key Observations:**
- **Net Debt/EBITDA:** 2.5x (Q3 FY2025) within target range of 2.0-2.5x, improved from 2.7x
- **Debt Structure:** 85% fixed rate debt, 3.6% weighted average interest rate - manageable
- **Credit Rating:** BBB+/Baa1 (S&P/Moody's) - investment grade, supporting access to capital
- **Debt Trend:** Net debt increased from $6.4B (FY2021) to $8.9B (FY2024), but ratio improving due to EBITDA growth

### Asset Quality
| Metric                        | 9/30/2024  | 9/30/2023  | 9/30/2022  | 9/30/2021  |
|-------------------------------|------------|------------|------------|------------|
| Goodwill                      | 16,725,000 | 16,772,000 | 17,350,000 | 18,335,000 |
| Other Intangible Assets       | 4,130,000  | 4,772,000  | 5,155,000  | 5,549,000  |
| Net Tangible Assets           | -4,757,000 | -4,999,000 | -6,237,000 | -6,322,000 |
| Total Assets                  | 42,695,000 | 42,242,000 | 42,158,000 | 41,890,000 |

**Key Observations:**
- **Goodwill:** $16.7B represents 39% of total assets - significant, but declining from $18.3B peak
- **Intangible Assets:** $4.1B declining, indicating amortization without major new acquisitions
- **Net Tangible Assets:** Negative -$4.8B reflects acquisition-heavy history, but improving trend
- **Asset Mix:** 49% goodwill/intangibles, indicating M&A-driven growth strategy

## Cash Flow Analysis

### Operating Cash Flow
| Metric                        | TTM        | 9/30/2024  | 9/30/2023  | 9/30/2022  | 9/30/2021  |
|-------------------------------|------------|------------|------------|------------|------------|
| Operating Cash Flow           | 3,367,000  | 2,098,000  | 2,221,000  | 1,990,000  | 2,487,000  |
| Free Cash Flow                | 2,868,000  | 1,604,000  | 1,775,000  | 1,503,000  | 1,935,000  |
| Adjusted Free Cash Flow       | --         | --         | --         | 1,791,000  | 912,000    |
| FCF Conversion Rate           | --         | --         | --         | >100%      | 64%        |

**Key Observations:**
- **Operating Cash Flow:** Strong TTM of $3.37B, recovering from FY2022 low of $1.99B
- **Free Cash Flow:** TTM of $2.87B demonstrates strong cash generation capability
- **FCF Conversion:** >100% achieved in FY2025 YTD, up from 64% in FY2024 - major improvement
- **Working Capital:** Improved receivables management driving cash conversion improvement

### Capital Allocation
| Metric                        | TTM        | 9/30/2024  | 9/30/2023  | 9/30/2022  | 9/30/2021  |
|-------------------------------|------------|------------|------------|------------|------------|
| Capital Expenditure           | -499,000   | -494,000   | -446,000   | -487,000   | -552,000   |
| Share Repurchases             | -1,340,000 | -1,246,000 | -625,000   | -1,441,000 | -1,307,000 |
| Dividends Paid                | -980,000   | -1,000,000 | -980,000   | -916,000   | -762,000   |
| Total Shareholder Returns     | -2,320,000 | -2,246,000 | -1,605,000 | -2,357,000 | -2,069,000 |

**Key Observations:**
- **Capital Expenditure:** ~$500M annually (~2% of revenue) - modest, focused on maintenance and growth
- **Share Repurchases:** $1.34B TTM, aggressive buyback program returning capital to shareholders
- **Dividends:** $980M TTM, ~$1.48 per share annualized, 1.3% yield - sustainable payout ratio
- **Total Returns:** Returning ~100% of free cash flow to shareholders as targeted

## Return Metrics

### Profitability Ratios
| Metric                        | TTM        | Period     |
|-------------------------------|------------|------------|
| Return on Assets              | 4.63%      | TTM        |
| Return on Equity              | 11.65%     | TTM        |
| Return on Invested Capital   | --         | --         |
| Profit Margin                 | 9.53%      | TTM        |
| Operating Margin              | 13.66%     | TTM        |

**Key Observations:**
- **ROA:** 4.63% is moderate, reflecting asset-intensive business model
- **ROE:** 11.65% reasonable but below industry leaders, indicating room for improvement
- **Profit Margin:** 9.53% TTM shows improving profitability trend
- **Operating Margin:** 13.66% TTM, with Q3 adjusted segment EBITA margin at 17.6%

## Financial Risk Assessment

### Key Risk Factors
1. **Working Capital:** Negative working capital of -$776M creates liquidity risk
2. **Leverage:** Net debt/EBITDA at 2.5x is manageable but requires consistent cash generation
3. **China Exposure:** APAC orders down 8% due to China softness, representing ~13% of revenue
4. **Goodwill:** $16.7B goodwill represents 39% of assets - potential impairment risk if businesses underperform
5. **Portfolio Review:** Strategic review ongoing - potential divestitures could impact financials

### Mitigating Factors
1. **Strong Cash Generation:** >100% FCF conversion provides liquidity buffer
2. **Investment Grade Rating:** BBB+/Baa1 maintains access to capital markets
3. **Record Backlog:** $14.6B provides revenue visibility and working capital support
4. **Operational Improvements:** Lean initiatives reducing working capital needs
5. **Fixed Rate Debt:** 85% fixed rate protects against interest rate volatility

## Outlook and Forecast

### Guidance Summary
- **FY2025 Revenue:** Mid-single-digit organic growth (reaffirmed)
- **FY2025 Margin:** ~90 bps adjusted segment EBITA margin expansion (reaffirmed)
- **FY2025 EPS:** $3.65-$3.68, up 14-15% (raised from ~$3.60)
- **FY2025 FCF Conversion:** >100% (raised from ~100%)
- **Q4 FY2025:** Low single-digit organic growth, 18.6% margin, $1.14-$1.17 EPS

### Long-Term Algorithm
- **Revenue Growth:** Mid-single-digit organic growth
- **Incrementals:** Well over 25% (targeting improvement through lean initiatives)
- **EPS Growth:** Double-digit growth
- **FCF Conversion:** 95%+ sustainable (targeting 100%+ with lean benefits)

## Conclusion

Johnson Controls demonstrates improving financial health with strong cash generation, accelerating margin expansion, and record backlog providing visibility. The company's focus on operational improvement through lean initiatives and portfolio optimization supports continued margin expansion. However, negative working capital, high leverage, and China exposure require monitoring. The new CEO's transformation initiatives show early promise but will take time to scale. Financial position is solid with investment-grade credit rating and disciplined capital allocation.

**Key Strengths:**
- Strong free cash flow generation (>100% conversion)
- Record backlog ($14.6B) providing visibility
- Accelerating margin expansion (17.6% segment EBITA)
- Investment-grade credit rating
- Disciplined capital allocation

**Key Concerns:**
- Negative working capital (-$776M)
- High leverage (68% debt/equity)
- China exposure risk
- Significant goodwill balance
- Margin gap to industry leaders

**Investment Thesis Support:** Financial metrics support a cautiously optimistic view. Strong execution and transformation initiatives provide upside potential, but portfolio review and operational improvements need time to materialize.

---

*Analysis based on financial data through Q3 FY2025 (ended June 30, 2025) and FY2024 annual results.*
